Hepatorenal Syndrome (HRS)

Hepatorenal Syndrome (HRS) is a topic covered in the Pocket ICU Management.

To view the entire topic, please or .

Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drugs, procedures, and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and PRIME Journals. Explore these free sample topics:

-- The first section of this topic is shown below --

First Things First (assess & treat for the following)

  • Assess airway, breathing, circulation
  • Determine the severity of liver disease, presence of ascites.
  • Assess intravascular volume status.
  • Assess renal function.
  • Consider admission of patient to intensive care unit.
  • Insert Foley catheter and measure strict intake/output.
  • If breathing is stable and there is no evidence of pulmonary edema, administer a trial of volume expansion using albumin infusion 1 g/kg IV (not to exceed 100 g).
  • Consider central venous pressure monitoring.
  • Adjust medications for renal and hepatic insufficiency
  • Determine the type of hepatorenal syndrome (HRS) if present.
    • Type 1 HRS: double creatinine to >2.5 mg/dL or 50% decrease in creatinine clearance to < 20 ml/min in < 2 weeks
    • Type 2 HRS: progressive decline in renal function with creatinine >1.5 mg/dL, paralleling the development of refractory ascites

-- To view the remaining sections of this topic, please or --

First Things First (assess & treat for the following)

  • Assess airway, breathing, circulation
  • Determine the severity of liver disease, presence of ascites.
  • Assess intravascular volume status.
  • Assess renal function.
  • Consider admission of patient to intensive care unit.
  • Insert Foley catheter and measure strict intake/output.
  • If breathing is stable and there is no evidence of pulmonary edema, administer a trial of volume expansion using albumin infusion 1 g/kg IV (not to exceed 100 g).
  • Consider central venous pressure monitoring.
  • Adjust medications for renal and hepatic insufficiency
  • Determine the type of hepatorenal syndrome (HRS) if present.
    • Type 1 HRS: double creatinine to >2.5 mg/dL or 50% decrease in creatinine clearance to < 20 ml/min in < 2 weeks
    • Type 2 HRS: progressive decline in renal function with creatinine >1.5 mg/dL, paralleling the development of refractory ascites

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: May 2, 2010